BloranDermatology Sciences
Est. 2021 · Boulder, CO
A clinician-first doorway into our 503B compounding facility. Co-prescribe adaptive regimens, receive structured diagnostic results back into your stack, and keep clinical authority exactly where it belongs — with you.
The handoff points between your practice and our Boulder compounding lab — written so a clinic operations lead could staff it on a Monday morning.
You flag a candidate from your panel — adult acne, reactive barrier, post-procedure recovery — and we ship a CLIA-validated microfluidic sampling kit to their door inside 48 hours, branded under your practice or ours.
The patient completes a 90-second barrier-and-microbiome sample and a 14-day skin diary logged inside the Bloran patient app. Telemetry streams to both the patient chart and a clinician-readable dashboard.
A licensed Bloran clinician (one of 22 on the advisory board, including 9 board-certified dermatologists) reviews every flagged regimen before compounding. You retain full override — pause, adjust actives, or decline.
On co-sign, our 18,000 sq ft Boulder lab compounds the 8-week regimen from raw APIs in biodegradable refill pods. Cold-chain delivery arrives inside 72 hours; you receive a batch-traceable lot record per shipment.
Patient diary data triggers auto-adjustment of the next refill — actives softened, ceramide ratios rebalanced, or barrier strategy swapped. Our algorithm proposes; you and the reviewing clinician dispose.
Bloran does not replace a dermatologist. We are the compounding and diagnostic layer that sits behind your prescription — the same way a 503B outsourcing facility sits behind a hospital pharmacy.
Every formulation is compounded in our FDA-registered, 18,000 sq ft Boulder facility from lot-traceable raw APIs to doorstep. Every flagged regimen is co-signed by a licensed clinician, not auto-shipped by software. Every batch carries a certificate of analysis you can pull at any time from the clinician portal.
What we will never do: make a diagnosis without clinician sign-off, ship an active-strength change without your review, or market a treatment as a cure for any diagnosed medical condition. The pen stays with you.
No rebuild required. The Bloran clinician portal exposes a structured read API (HL7 FHIR-aligned) and ships embeddable modules for the telehealth platforms your practice already runs on.
Diagnostic results, formulation lot records, refill history, and diary telemetry return as FHIR-aligned resources to your EMR via secure SFTP or REST webhook. No double-entry charting.
A white-labelable iframe and an iFrame-less React widget let your existing derm-platform surface the kit, the consent flow, and the result dashboard inside a patient visit — without a tab switch.
Daily diary entries, irritation flags, adherence metrics, and qualitative self-reports stream to a clinician-readable dashboard — sortable by patient, by cohort, by regimen revision. Useful for in-practice review.
For practices onboarding 50+ patients a quarter: CSV roster import, automated kit dispatch templating, and a per-clinician referral link with UTM-tagged lot recall. Your office manager, not your billing team, runs it.
Solo, group, or academic practice
Co-prescribe adaptive regimens for the patients already in your panel — reactive barrier, adult acne, periorbital sensitivity, post-procedure recovery. Receive diagnostic results as FHIR resources back into your EMR. Keep override authority on every active and every strength.
Independent practice or medi-spa
For licensed estheticians working under a supervising dermatologist, Bloran offers a referral-tier workflow: flag candidates from your treatment room, route the diagnostic through your medical director, receive the compounded regimen under your brand of choice for in-studio home-care prescribing.
D2C platforms, virtual clinics, payers
Embed the Bloran diagnostic, consent flow, and refill management directly into your existing telehealth product. The React widget handles kit dispatch, sample return, result delivery, and refill cadence — surfaced under your brand, powered by our Boulder lab.
Sitting on our 22-person clinical advisory board — out of 22 licensed clinicians and 14 PhD scientists on the full team. Every flagged regimen is reviewed by a human before it ships, not just an algorithm.
Published across JCAD, JDD, and the British Journal of Dermatology since 2022. Most recent: ceramide-restore efficacy for sensitive-skin phenotypes, JCAD March 2024. Full bibliography available on request.
Across 14,200+ diagnostic kits shipped since 2021, our at-home microfluidic sampling matched the treating dermatologist's clinical assessment within one phenotype bucket — independently audited.
Bloran is the only derm-brand partner of the National Eczema Association. The NEA Seal of Acceptance appears on every sensitive-skin regimen shipped to enrolled patients under our clinician network.
Request clinician access — most applications are reviewed within two business days. A partnerships lead will route you to the right onboarding tier.
Request Clinician Access [email protected]